Internal Medicine, Infectious Disease · Reno, NV
NPI
1164434130
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
6130 Plumas St
Reno, NV, 89519
Phone (775) 327-5000
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,872
72 services
Medicare patients, 2024
40
Average age 72
Drug cost, 2024
$3.1M
1,534 prescriptions
Company payments
-
None reported
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Charles Krasner was code 99213 (office e&m - established), 19 times for 14 patients. In total Charles Krasner billed 72 services in 16 codes, and Medicare paid $4,872.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-12-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 19 | 14 | $57.39 | $1,090 |
| 99221 Hospital E&M - Initial | Facility | 15 | 15 | $64.01 | $960 |
By year: 2022 $7,184 for 109 services; 2023 $11K for 155 services; 2024 $4,872 for 72 services.
Medicare prescription drug claims, 2024
In 2024, the drug Charles Krasner prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 372 prescriptions and refills. In total Charles Krasner wrote 1,534 Medicare prescriptions that cost $3.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 372 | 372 | 47 | $1.4M |
| Tivicay Dolutegravir Sodium | 183 | 186 | 20 | $403K |
| Descovy Emtricitabine/Tenofov Alafenam | 178 | 180 | 20 | $379K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 80 | 80 | 13 | $289K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 49 | 49 | Under 11 | $203K |
| Prezcobix Darunavir/Cobicistat | 32 | 32 | Under 11 | $82K |
| Omeprazole Generic | 32 | 38 | Under 11 | $173 |
| Rosuvastatin Calcium Generic | 29 | 31 | Under 11 | $415 |
| Atorvastatin Calcium Generic | 29 | 39 | Under 11 | $71.71 |
| Lisinopril Generic | 26 | 32 | Under 11 | $61.77 |
| Isentress Raltegravir Potassium | 24 | 24 | Under 11 | $47K |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 24 | 36 | Under 11 | $153 |
| Sertraline Hcl Generic | 22 | 22 | Under 11 | $52.7 |
| Gabapentin Generic | 21 | 23 | Under 11 | $178 |
| Juluca Dolutegravir/Rilpivirine | 18 | 18 | Under 11 | $62K |
Brand drugs: 1,035 claims; generic drugs: 499 claims; opioid claims: 25.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Charles Krasner were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.